ACR 0.00% 6.6¢ acrux limited

top biotech : great opportunity, page-2

  1. 92 Posts.
    more news.......

    Acrux Signs Second Commercial Agreement with Organon
    Wednesday March 7, 2007, 8:36 am

    Original Announcement: Second commercial agreement with Organon

    Acrux has entered into an agreement with Organon in relation to Acrux's technology for delivery of a non-hormone, proprietary Organon drug. Acrux will be responsible for developing formulations of the undisclosed compound and upon completion, Organon will undertake and fund all clinical trials, regulatory submissions, manufacturing and commercialization efforts. Acrux may receive payments totalling US$12m as development and regulatory milestones are achieved. Acrux will also earn royalties on worldwide sales of the product.
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
0.000(0.00%)
Mkt cap ! $19.18M
Open High Low Value Volume
6.5¢ 6.8¢ 6.5¢ $2.852K 42.56K

Buyers (Bids)

No. Vol. Price($)
2 10347 6.5¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 100000 1
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.